文献速递心境障碍焦虑、强迫与应激相关障碍精神分裂症与精神病性障碍

成人精神障碍的认知行为治疗:一项统一的系列荟萃分析

Cognitive Behavior Therapy for Mental Disorders in Adults: A Unified Series of Meta-Analyses.
PubMed 文献 · JAMA Psychiatry · 2025-01-01

该系列荟萃分析纳入375项随机临床试验(423项比较,32968例患者),用统一方法评估认知行为治疗(CBT)对多种成人精神障碍的症状疗效。CBT对双相和精神病性障碍的效应量低于0.5,对惊恐、社交焦虑、广泛性焦虑、神经性贪食、暴食障碍、抑郁和强迫症在0.5至1.0之间,对创伤后应激障碍和特定恐惧症大于1.0;效应量取决于对照条件类型。

要点

  • CBT对抑郁、焦虑、创伤后应激障碍、强迫症和进食障碍可能有效,对精神病性和双相障碍可能有效。
  • 效应量因对照条件而异:等待名单对照试验效应量大(g>0.94),常规照护对照效应量较温和(0.22-1.13)。
  • CBT组脱组率从特定恐惧症的8%到创伤后应激障碍的24%。

核心结论

  • 在这项统一的系列荟萃分析中,CBT对抑郁、焦虑、创伤后应激障碍、强迫症和进食障碍可能有效,对精神病性和双相障碍可能有效。
  • 效应量取决于对照条件的类型。

研究设计与样本

  • 检索PubMed、PsycINFO和Embase至2024年1月1日,按疾病分别检索。
  • 纳入比较CBT与 inactive 对照条件的随机临床试验,对象为经临床访谈确诊的成人精神障碍患者。
  • 共纳入375项试验(423项比较),32968例患者;患者平均(SD)年龄43.4(13.7)岁,女性平均(SD)比例0.68(0.24)。
  • 使用Cochrane RoB 2工具评估偏倚风险,采用随机效应模型进行荟萃分析。
  • 数据分析于2024年8月至2025年1月进行。

主要发现

  • CBT与所有对照条件比较的效应量(g):双相障碍0.31,精神病性障碍低于0.5。
  • 惊恐障碍、社交焦虑障碍、广泛性焦虑障碍、神经性贪食、暴食障碍、抑郁和强迫症的效应量在0.5至1.0之间。
  • 创伤后应激障碍和特定恐惧症的效应量大于1.0,范围从双相障碍的0.31到创伤后应激障碍的1.27。
  • 等待名单对照试验观察到大的效应量(g>0.94),常规照护对照试验效应量较温和(0.22-1.13)。
  • CBT组内脱组率从特定恐惧症的8%到创伤后应激障碍的24%。

关键数值与推荐

  • 主要结局为治疗后CBT与对照在相应障碍症状上的标准化均数差(Hedges g)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Cognitive behavior therapy (CBT) is a first-line treatment for most mental disorders. However, no meta-analytic study has yet integrated the results of randomized clinical trials on CBT across different disorders, using uniform methodologies and providing a complete overview of the field. OBJECTIVE: To examine the effect sizes of CBT for 4 anxiety disorders, 2 eating disorders, major depression, obsessive-compulsive disorder (OCD), posttraumatic stress disorder (PTSD), and psychotic and bipolar disorders on symptoms of the respective disorders using uniform methodologies for data extraction, risk of bias (RoB) assessment, and meta-analytic techniques. DATA SOURCES: Major bibliographical databases (PubMed, PsycINFO, and Embase for all disorders) were searched up to January 1, 2024, for each disorder separately. Data analysis was performed from August 2024 to January 2025. STUDY SELECTION: Randomized clinical trials comparing CBT with inactive control conditions in adults with 1 of the mental disorders established through a clinical interview were included. DATA EXTRACTION AND SYNTHESIS: Basic characteristics of patients, CBT, and studies were extracted. RoB was assessed with the Cochrane RoB tool 2. Meta-analyses were conducted using random-effects models. MAIN OUTCOMES AND MEASURES: The primary outcome was the standardized mean difference (Hedges g) indicating the difference between CBT and controls at posttreatment on symptoms of the respective disorders. RESULTS: A total of 375 trials (423 comparisons) between CBT and controls were included among 32 968 patients. The overall mean (SD) patient age was 43.4 (13.7) years, and the mean (SD) proportion of women was 0.68 (0.24). Effect sizes for CBT compared to all control conditions (g) were lower than 0.5 for bipolar and psychotic disorder; between 0.5 and 1.0 for panic, social anxiety, and generalized anxiety disorders, bulimia nervosa, binge eating disorders, depression, and OCD; and larger than 1.0 for PTSD and specific phobias (range of effect sizes: 0.31 for bipolar disorder to 1.27 for PTSD). Large effect sizes (g > 0.94) were observed in waitlist-controlled trials, a control condition mostly used in anxiety and eating disorders, PTSD, and OCD. Trials using care as usual showed more modest effect sizes (0.22-1.13). Study dropout rates within the CBT conditions ranged from 8% for specific phobia to 24% for PTSD. CONCLUSIONS AND RELEVANCE: In this unified series of meta-analyses, CBT was probably effective in the treatment of mental disorders, including major depression, anxiety disorders, PTSD, OCD, and eating disorders, and possibly effective in psychotic and bipolar disorders. However, the effect sizes depended on the type of control condition.

来源:JAMA Psychiatry,查看原文。版权归原作者所有。

引用

  1. Cuijpers P, Harrer M, Miguel C, et al. Cognitive Behavior Therapy for Mental Disorders in Adults: A Unified Series of Meta-Analyses. JAMA Psychiatry. 2025. PMID: 40238104. doi:10.1001/jamapsychiatry.2025.0482

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。